Stay updated on ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Sign up to get notified when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.

Latest updates to the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page
- Check3 days agoChange DetectedThe page's revision tag was updated from v3.6.2 to v3.6.3. This is a minor metadata update to the study record rather than a substantive change to the content.SummaryDifference0.1%

- Check11 days agoChange DetectedThe page revision label was updated from v3.6.0 to v3.6.2, indicating a newer version of the page. This update reflects a minor maintenance or content update without altering the study details presented.SummaryDifference0.1%

- Check18 days agoNo Change Detected
- Check25 days agoChange DetectedAdded recruitment status notice 'No longer looking for participants' and new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study) along with an updated Intervention/Treatment heading. The old Intervention / Treatment label and the previous revision tag (v3.5.5) were removed, and the revision tag now shows v3.6.0.SummaryDifference0.4%

- Check32 days agoChange DetectedThe study page now shows Revision: v3.5.5, replacing the previous v3.5.4. This represents a minor update to the page's metadata and rendering without altering study data or user actions.SummaryDifference0.1%

- Check54 days agoChange DetectedThe revision label on the page was updated from v3.5.3 to v3.5.4, signaling a new version of the page content. This appears to be an editorial or QC update rather than a substantive change to the study details or outcomes.SummaryDifference0.1%

- Check75 days agoChange DetectedThe page’s displayed system “Revision” number has been updated from v3.5.2 to v3.5.3.SummaryDifference0.1%

Stay in the know with updates to ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial.
Enter your email address, and we'll notify you when there's something new on the ASLAN004 SubQ in Atopic Dermatitis: Safety Clinical Trial. page.